Additionally, 50 nM of NSC606985 also effectively reduced C/EBPα protein together with the cleaved activation of PKCδ (Figure 1B) and apoptosis induction (data not shown) in primary leukemic cells from bone marrow (BM) of two AML patients. This evidence concerns the gene CEBPA and acute myeloid leukemia.